In this context, we designed a novel strategy of inhibition of GRK2 by mimicking the HJ loop of the kinase which was effective for the treatment of cardiac hypertrophy [36] and of diabetes and its cardiovascular complications [34]. The gene discussed is GRK2; the disease is diabetes mellitus.